Summary
We investigated the alteration of oligodendrocytes in comparison with that of astrocytes and microglia in the mouse striatum after MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropridine) treatment under the same conditions using Western blot analysis and Immunohistochemistry. In our Western blot analysis, four administrations of MPTP at 2-h intervals to mice produced the remarkable loss of TH (tyrosine hydroxylase) protein levels in the striatum after 3 and 7 days. In contrast, GFAP (glial fibrillary acidic protein) and Iba-1 protein in the striatum showed a significant increase of GFAP and Iba-1 protein levels 3 and 7 days after MPTP treatment. On the other hand, the levels of CNPase (2′, 3′-cyclic nucleotide 3′-phosphodiesterase) protein were decreased significantly in the striatum 3 and 7 days after MPTP treatment. In our immunohistochemical study, a significant decrease in the area of expression of CNPase-positive profiles was observed in the striatum 3 and 7 days after MPTP treatment.
These results demonstrate that oligodendrocytes in the striatum are damaged after MPTP treatment. Thus our present findings provide valuable information for the pathogenesis of Parkinson’s disease.
Similar content being viewed by others
References
D Dewar D Dawson (1995) ArticleTitleTau protein is altered by focal cerebral ischemia in the rat: an immunohistochemical and immunoblotting study Brain Res 684 70–78 Occurrence Handle7583206 Occurrence Handle10.1016/0006-8993(95)00417-O Occurrence Handle1:CAS:528:DyaK2MXms1ylsrk%3D
LK Felzein JT McDonald SM Gleason NEJ Berman RM Kein (2001) ArticleTitleIncreased chemokine gene expression during aging in the murine brain Brain Res 890 137–146 Occurrence Handle10.1016/S0006-8993(00)03090-0
B Ferger A Leng A Mura B Hengerer J Feldon (2004) ArticleTitleGenetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum J Neurochem 89 822–833 Occurrence Handle15140182 Occurrence Handle10.1111/j.1471-4159.2004.02399.x Occurrence Handle1:CAS:528:DC%2BD2cXksVyksL8%3D
MM Gresle B Jarrott NM Jones JK Gallaway (2006) ArticleTitleInjury to axons and oligodendrocytes following endothelin-1-induced middle cerebral artery occlusion in conscious rats Brain Res 1110 13–22 Occurrence Handle16905121 Occurrence Handle10.1016/j.brainres.2006.06.111 Occurrence Handle1:CAS:528:DC%2BD28Xps1Crsr8%3D
D Guillian DG Young J Woodward DC Brown LB Lachman (1988) ArticleTitleInterleukin-1 is an astroglial growth factor in the developing brain J Neurosci 8 709–714
HP Hartung SF Jung G Stroll J Zielasek B Schmidt JJ Archelos KV Toyka (1992) ArticleTitleInflammatory mediators in demyelinating disorders of the CNS and PNS J Neuroimmunol 40 197–210 Occurrence Handle1331168 Occurrence Handle10.1016/0165-5728(92)90134-7 Occurrence Handle1:CAS:528:DyaK3sXnvVKkug%3D%3D
N Hayakawa H Kato T Araki (2007) ArticleTitleAge-related changes of astorocytes, oligodendrocytes and microglia in the mouse hippocampal CA1 sector Mech Ageing Dev 128 311–316 Occurrence Handle17350671 Occurrence Handle10.1016/j.mad.2007.01.005 Occurrence Handle1:CAS:528:DC%2BD2sXksVOmurY%3D
J Hirrlinger JB Schulz R Dringen (2002) ArticleTitleEffects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson’s disease J Neurochem 82 458–467 Occurrence Handle12153471 Occurrence Handle10.1046/j.1471-4159.2002.01013.x Occurrence Handle1:CAS:528:DC%2BD38Xmt1ejs7o%3D
S Hisahara H Okano M Miura (2003) ArticleTitleCaspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination Neurosci Res 46 387–397 Occurrence Handle12871760 Occurrence Handle10.1016/S0168-0102(03)00127-5 Occurrence Handle1:CAS:528:DC%2BD3sXlsVait7c%3D
EM Holgado JM Vela AA Martin C Cuaza (2001) ArticleTitleLPS/IFN-γ cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10 Eur J Neurosci 13 493–502 Occurrence Handle10.1046/j.0953-816x.2000.01412.x
H Imai H Masayasu D Dewar DI Graham IM Macrae (2001) ArticleTitleEbselen protects both gray and white matter in a rodent model of focal cerebral ischemia Stroke 32 2149–2154 Occurrence Handle11546910 Occurrence Handle10.1161/hs0901.095725 Occurrence Handle1:CAS:528:DC%2BD3MXnt1Gjurg%3D
EA Irving K Yatsushiro J McCulloch D Dewar (1997) ArticleTitleRapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals J Cereb Blood Flow Metab 17 612–622 Occurrence Handle9236718 Occurrence Handle10.1097/00004647-199706000-00003 Occurrence Handle1:CAS:528:DyaK2sXlsVGiuro%3D
P Jenner (2003) ArticleTitleOxidative stress in Parkinson’s disease Ann Neurol 53 S26–S38 Occurrence Handle12666096 Occurrence Handle10.1002/ana.10483 Occurrence Handle1:CAS:528:DC%2BD3sXjtFGitLs%3D
H Kato R Kurosaki C Oki T Araki (2004) ArticleTitleArundic acid, an astrocyte-modulating agent, protects dopaminergic nuurons against MPTP neurotoxicity in mice Brain Res 1030 66–73 Occurrence Handle15567338 Occurrence Handle10.1016/j.brainres.2004.09.046 Occurrence Handle1:CAS:528:DC%2BD2cXhtVantL7K
HK Kimelberg HK Norenberg (1989) ArticleTitleAstrocytes Sci Am 260 66–72 Occurrence Handle2564697 Occurrence Handle1:STN:280:DyaL1M7os1yhtQ%3D%3D Occurrence Handle10.1038/scientificamerican0489-66
R Kurosaki Y Muramatsu H Kato T Araki (2004) ArticleTitleBiochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson’s disease Pharmacol Biochem Behav 78 143–153 Occurrence Handle15159144 Occurrence Handle10.1016/j.pbb.2004.03.006 Occurrence Handle1:CAS:528:DC%2BD2cXkt1Srsbw%3D
NJ Laping B Teter NR Nichols I Rozovsky CE Finch (1994) ArticleTitleGlial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors Brain Pathol 4 259–275 Occurrence Handle7952267 Occurrence Handle1:CAS:528:DyaK2MXhtVKltbs%3D
B Liu JS Hong (2003) ArticleTitleRole of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention J Pharmacol Exp Ther 304 1–7 Occurrence Handle12490568 Occurrence Handle10.1124/jpet.102.035048 Occurrence Handle1:CAS:528:DC%2BD3sXhtF2qug%3D%3D
E McCacken JH Fowler D Dewar S Morrison J McCulloch (2002) ArticleTitleGrey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist SPD 502 J Cereb Blood Flow Metab 22 1090–1097 Occurrence Handle10.1097/00004647-200209000-00006
RC Melcangi V Magnaghi I Cavarretta MA Riva F Piva L Martin (1998) ArticleTitleEffects of steroid hormones on gene expression of glial markers in the central and peripheral nervous system: variations induced by aging Exp Gerontol 33 827–836 Occurrence Handle9951626 Occurrence Handle10.1016/S0531-5565(98)00020-5 Occurrence Handle1:CAS:528:DyaK1MXjtVClsw%3D%3D
Y Muramatsu R Kurosaki H Watanabe M Michimata M Matsubara Y Imai T Araki (2003) ArticleTitleExpression of S-100 protein is related to neuronal damage in MPTP-treated mice Glia 42 307–313 Occurrence Handle12673835 Occurrence Handle10.1002/glia.10225
H Nawashiro M Brenner S Fukui K Shimada JM Hallenbeck (2000) ArticleTitleHigh susceptibility to cerebral ischemia in GFAP-null mice J Cereb Blood FlowMetab 20 1040–1044 Occurrence Handle10.1097/00004647-200007000-00003 Occurrence Handle1:CAS:528:DC%2BD3cXltFOmur0%3D
CW Olanov AH Schapira Y Agid (2003) ArticleTitleNeuroprotection of Parkinson’s disease: Prospects and promises Ann Neurol 53 IssueIDSuppl 3 S1–S2 Occurrence Handle10.1002/ana.10566
JL Ridet SK Malhotra A Privat FH Gage (1997) ArticleTitleReactive astrocytes: cellular and molecular cues to biological function Trends Neurosci 20 570–577 Occurrence Handle9416670 Occurrence Handle10.1016/S0166-2236(97)01139-9 Occurrence Handle1:CAS:528:DyaK2sXnvFWnt7c%3D
A Tanaka Y Watanabe H Kato T Araki (2007) ArticleTitleImmunohistochemical changes related to ageing in the mouse hippocampus and subventricular zone Mech Ageing Dev 128 303–310 Occurrence Handle17316762 Occurrence Handle10.1016/j.mad.2007.01.002 Occurrence Handle1:CAS:528:DC%2BD2sXksVOmurg%3D
J Tanaka Y Okuma K Tomobe Y Nomura (2005) ArticleTitleThe age-related degeneration of oligodendrocytes in the hippocampus of the senescence-accelerated mouse (SAM)P8: a Quantitative immunohistochemical study Biol Pharm Bull 28 615–618 Occurrence Handle15802797 Occurrence Handle10.1248/bpb.28.615 Occurrence Handle1:CAS:528:DC%2BD2MXksFagsr4%3D
R Vlkolinsky N Cairns M Fountoulaks G Lubec (2001) ArticleTitleDecreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer’s disease Neurobiol Aging 22 547–553 Occurrence Handle11445254 Occurrence Handle10.1016/S0197-4580(01)00218-4 Occurrence Handle1:CAS:528:DC%2BD3MXltVCqtrg%3D
H Watanabe Y Muramatsu R Kurosaki M Michimata M Matsubara Y Imai T Araki (2004) ArticleTitleProtective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neuotoxicity: an immunohistological study Eur Neuropsychopharmacol 14 93–104 Occurrence Handle15013024 Occurrence Handle10.1016/S0924-977X(03)00065-8 Occurrence Handle1:CAS:528:DC%2BD2cXpsVyruw%3D%3D
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takagi, S., Hayakawa, N., Kimoto, H. et al. Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice. J Neural Transm 114, 1553–1557 (2007). https://doi.org/10.1007/s00702-007-0790-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-007-0790-9